Predicting Response to Depression Treatment

Informazioni relative al progetto

PReDicT

ID dell’accordo di sovvenzione: 696802

DOI

10.3030/696802

Progetto chiuso

Data della firma CE 10 Dicembre 2015

Data di avvio 1 Ottobre 2015

Data di completamento 30 Novembre 2019

Finanziato da

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Costo totale

€ 4 092 630,25

Contributo UE

€ 4 092 630,25

Coordinato da

P1VITAL LIMITED
United Kingdom

CORDIS fornisce collegamenti ai risultati finali pubblici e alle pubblicazioni dei progetti ORIZZONTE.

I link ai risultati e alle pubblicazioni dei progetti del 7° PQ, così come i link ad alcuni tipi di risultati specifici come dataset e software, sono recuperati dinamicamente da .OpenAIRE .

Risultati finali

Documents, reports (6)

Publications submitted to peer reviewed journals
Quarterly project reports
Stakeholder reports (Assessment, Engagement and Impact)
Periodic and final reports
Clinical study reports of clinical effectiveness, cost effectiveness and clinical utility
Executive leadership team established. Project and financial reporting procedures agreed

Executive leadership team established. Project and financial reporting procedures agreed

Other (3)

Supplemental release of the eH-ETB during WP2 clinical study
Technical file updated, Self-declaration of conformity and registration of eH-ETB as a Class 1 medical device
Initial release of eH-ETB for use in WP2 clinical study

Websites, patent fillings, videos etc. (3)

Communication of results (Publications, Conference presentations, Stakeholder meetings, Press releases)
Project website live
Regular project newsletters

Demonstrators, pilots, prototypes (4)

Interim analysis report of Part A
Study protocol finalised and approved
Country specific Ethics approvals obtained
Study agreements executed with health centres

Pubblicazioni

Peer reviewed articles (1)

The effects of using the PReDicT Test to guide the antidepressant treatment of depressed patients: study protocol for a randomised controlled trial

Autori: Jonathan Kingslake, Rebecca Dias, Gerard R. Dawson, Judit Simon, Guy M. Goodwin, Catherine J. Harmer, Richard Morriss, Susan Brown, Boliang Guo, Colin T. Dourish, Henricus G. Ruhé, Anne G. Lever, Dick J. Veltman, Anneke van Schaik, Jürgen Deckert, Andreas Reif, Michael Stäblein, Andreas Menke, Philip Gorwood, Géraldine Voegeli, Victor Pérez, Michael Browning
Pubblicato in: Trials, Numero 18/1, 2017, Pagina/e 558, ISSN 1745-6215
Editore: BioMed Central
DOI: 10.1186/s13063-017-2247-2

Other (1)

Statistical Analysis Plan for the Predict Trial

Autori: Browning, Michael
Pubblicato in: Numero 1, 2018
Editore: Zenodo
DOI: 10.5281/zenodo.1235967